National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.

Neil MehtaJennifer L DodgeJoshua D GrabFrancis Y Yao

Published in: Hepatology (Baltimore, Md.) (2019)

Our results validated UNOS-DS criteria based on comparable 3-year survival between UNOS-DS and Milan groups. Additional refinements based on AFP and wait time may further improve post-LT outcomes in down-staging groups, especially given that reported 3-year recurrence was higher than in those always within Milan criteria.

Keyphrases

lymph node
pet ct
free survival
quality improvement
risk factors
type diabetes
metabolic syndrome
insulin resistance
glycemic control